Two Biotechnology Names Are Hot: Incyte Corporation (INCY), Anacor Pharmaceuticals, Inc. (ANAC)
Zergwatch 18.7%, respectively; P<0.0001)1 without the need for phlebotomy in patients with inadequately controlled polycythemia vera (PV) resistant to or intolerant of hydroxyurea (HU) who did not have an enlarged spleen. The safety profile of Jakafi was ... |
from phlebotomy - Google News http://bit.ly/28MFBai
No comments:
Post a Comment